HanesBrands (HBI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A definitive merger agreement was signed on August 13, 2025, for the acquisition of Hanesbrands by Gildan through a multi-step transaction structure, including several mergers and a conversion to a limited liability company.
Hanesbrands stockholders will receive 0.102 Gildan shares and $0.80 in cash per Hanesbrands share, with the exchange ratio fixed and subject to adjustment if Gildan’s share issuance exceeds 24.99% of its outstanding shares.
The implied value of the merger consideration was $6.00 per Hanesbrands share at announcement, representing a 24.1% premium to the unaffected price, and $6.85 per share as of October 1, 2025.
Upon completion, former Hanesbrands stockholders will own approximately 19.49% of Gildan, with Gildan shareholders holding the remaining 80.51%.
The special meeting for Hanesbrands stockholders to vote on the merger is scheduled for November 25, 2025.
Voting matters and shareholder proposals
Stockholders are asked to vote on: (1) approval of the merger and related transactions, (2) a non-binding advisory vote on executive compensation related to the merger, and (3) adjournment of the meeting if more votes are needed.
The board unanimously recommends voting “FOR” all proposals.
Approval of the merger requires a majority of outstanding shares; abstentions and non-votes count as “AGAINST.”
No appraisal rights are available to Hanesbrands stockholders.
Board of directors and corporate governance
The current Gildan board and management are expected to remain in place after the transaction.
Hanesbrands directors and executive officers have interests in the transaction that may differ from other stockholders, including treatment of equity awards and severance benefits.
Latest events from HanesBrands
- Adjusted profit and margin growth drive strong Q2; Champion sale to fund $1B debt paydown.HBI
Q2 20242 Feb 2026 - Record margin, profit growth, and debt reduction set the stage for continued improvement.HBI
Q3 202416 Jan 2026 - Sales, margins, and cash flow exceeded expectations; 2025 targets margin gains and lower leverage.HBI
Q4 202422 Dec 2025 - 2024 saw margin growth, debt reduction, and ESG progress; key votes include board, pay, and equity plan.HBI
Proxy Filing1 Dec 2025 - Definitive proxy materials filed for shareholder voting, with no fee required.HBI
Proxy Filing1 Dec 2025 - $4.4B merger forms global apparel leader, targeting $200M synergies and 23% EBITDA margin.HBI
M&A Announcement25 Nov 2025 - Q2 2025 profit and margin gains drove a raised full-year outlook amid ongoing cost savings.HBI
Q2 202523 Nov 2025 - Q1 2025 saw higher sales, margin gains, and improved leverage despite tariff and market headwinds.HBI
Q1 202520 Nov 2025 - Operating profit up 14% and EPS surged on tax benefit, with Gildan acquisition pending.HBI
Q3 20256 Nov 2025